Showing results (251-260 of 307) with videos related to

Sort By:
Pageof 31
Reproductive Biomedicine Online|July 17, 2012
Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized studyDimitra Kyrou, Efstratios M Kolibianakis, Human M Fatemi, et al.
Journal of Assisted Reproduction and Genetics|June 18, 2024
Optimized sperm selection: a highly efficient device for the isolation of progressive motile sperm with low DNA fragmentation indexIleana Mateizel, Annalisa Racca, Eleni Aligianni, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2015
Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian respondersNikolaos P Polyzos, Roberta Corona, Arne Van De Vijver, et al.
Frontiers in Endocrinology|May 20, 2020
Impact of Serum Estradiol Levels Prior to Progesterone Administration in Artificially Prepared Frozen Embryo Transfer CyclesShari Mackens, Samuel Santos-Ribeiro, Ellen Orinx, et al.
Human Reproduction (Oxford, England)|October 11, 2018
Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trialGeorg Griesinger, Christophe Blockeel, Gennady T Sukhikh, et al.
Human Reproduction (Oxford, England)|September 20, 2020
Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?Shari Mackens, Stéphanie Pareyn, Panagiotis Drakopoulos, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 14, 2014
Ovarian hyperstimulation syndrome inhibition by targeting VEGF, COX-2 and calcium pathways: a preclinical randomized studyChrysoula Kitsou, Ioannis Kosmas, Leandros Lazaros, et al.
Environment International|August 21, 2015
Human exposure to endocrine disrupting chemicals and fertility: A case-control study in male subfertility patientsElly Den Hond, Herman Tournaye, Petra De Sutter, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 15, 2015
Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled studyIoannis P Kosmas, Chrysoula Kitsou, Leandros Lazaros, et al.
Pageof 31